Clinuvel Pharmaceuticals Limited

A$7.52As of Sun 8 Nov 2026, 12:00 UTC
ASX:CUVHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (0.93%)
Div yield 0.66%
ROE 13.21%
Biotechnology
Beta (5Y) 0.51
PE TTM 11.26
TSR TTM (34.22%)
Mkt cap A$379.2M
ROIC 126.71%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$9.24
22.87%
(44.81%)
Hold 7|0|11|2|9
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.14
0.14
0.15
0.17
4.23%
8.70%
15.01%
23.05%
Revenue$M
30.46
30.42
29.91
31.57
11.66%
7.96%
0.73%
4.77%
Peers (US$260.5M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.574
(0.298)
(0.207)
EBIT/Intx
0.325
1.270
1.247
Own earn%
(226.02)
(24.34)
(23.07)
Sh yield%
11.48
55.96
54.99
Owners
Insiders/Inst%
9.40
27.62
Short interest%
2.73
SBC / revenue%
3.50
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
25–29
$1 testx
—
Incr. ROIC%
2